🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
iX Biopharma Ltd. (SGX:42C)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.4550
0.00 (0.00%)
At close: Nov 18, 2026

iX Biopharma Revenue

iX Biopharma had revenue of 2.71M SGD in the quarter ending September 30, 2026, with 70.58% growth. This brings the company's total for the last twelve months to 7.96M, up 6.17% year-over-year. In the fiscal year ending June 30, 2026, iX Biopharma had annual revenue of 6.85M, down -11.77%. That makes iX Biopharma the 39,302nd largest company in the world by revenue and 473rd in Singapore.

Revenue (ttm)
7.96M
Revenue Growth
+6.17%
P/S Ratio
62.49
Revenue / Employee
215.16K
Employees
37
Market Cap
497.46M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Specialty Pharmaceuticals 5.63M 76.9%
  • Nutraceutical 1.69M 23.1%

By Geography

Chart
  • Australia 3.78M 55.2%
  • United States of America 1.98M 28.9%
  • China 675.00K 9.8%
  • Singapore and Others 416.00K 6.1%
Fiscal year ended Jun 30, 2026 See the full iX Biopharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20266.85M-914.00K-11.77%
Jun 30, 20257.77M1.81M30.34%
Jun 30, 20245.96M46.00K0.78%
Jun 30, 20235.91M-8.48M-58.91%
Jun 30, 202214.39M12.65M724.64%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.